Desjardins Has Lowered Expectations for Andean Precious Metals (CVE:APM) Stock Price

Andean Precious Metals (CVE:APM) had its target price lowered by Desjardins from C$2.10 to C$2.00 in a research note published on Thursday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

Andean Precious Metals Stock Up 7.5 %

Shares of CVE:APM opened at C$1.29 on Thursday. Andean Precious Metals has a 12 month low of C$0.57 and a 12 month high of C$2.18. The company’s 50-day moving average price is C$1.29 and its two-hundred day moving average price is C$1.36. The firm has a market cap of C$135.47 million, a P/E ratio of 2.55 and a beta of 1.22.

Insiders Place Their Bets

In other news, Senior Officer Juan Carlos Sandoval Amare purchased 31,300 shares of the firm’s stock in a transaction that occurred on Friday, January 3rd. The shares were acquired at an average price of C$1.21 per share, for a total transaction of C$37,860.48. Insiders own 69.37% of the company’s stock.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.